Nestin+ niches are reduced in humans or mice with chronic myeloproliferative neoplasms (Arranz et al., 2014), which can be considered preleukemic disorders due to their higher incidence of leukemic transformation. This evidence concerns the gene NES and myeloproliferative neoplasm.